Jazz Pharmaceuticals plc — Director's Dealing 2015

Jun 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-06-01

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-01	Ordinary Shares	M	1500.0	$59.13	Acquired	27399	Direct
2015-06-01	Ordinary Shares	S	1500.0	$179.75	Disposed	25899	Direct
2015-06-01	Ordinary Shares	M	3994.0	$46.83	Acquired	29893	Direct
2015-06-01	Ordinary Shares	S	3994.0	$179.5	Disposed	25899	Direct
2015-06-02	Ordinary Shares	S	257.0	$180.0	Disposed	25642	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-01	Non-Qualified Stock Option (right to buy)	$46.83	M	3994.0	Disposed	2022-08-08	Ordinary Shares (3994)	Direct
2015-06-01	Non-Qualified Stock Option (right to buy)	$59.13	M	1500.0	Disposed	2023-03-04	Ordinary Shares (1500)	Direct

Footnotes

F1: Includes 257 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2015.

F2: As of the date of this report, the remaining ordinary shares subject to this option will vest with respect to 3,843 shares in equal monthly installments from June 9, 2015 to December 9, 2015 and with respect to 2,865 shares in equal monthly installments from January 9, 2016 to August 9, 2016.

F3: As of the date of this report, the remaining ordinary shares subject to this option will vest in equal monthly installments from June 5, 2015 to December 5, 2016.